4XJ0

Crystal structure of ERK2 in complex with an inhibitor 14K


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.58 Å
  • R-Value Free: 0.244 
  • R-Value Work: 0.208 
  • R-Value Observed: 0.210 

wwPDB Validation 3D Report Full Report



Literature

Discovery of highly potent, selective, and efficacious small molecule inhibitors of ERK1/2.

Ren, L.Grina, J.Moreno, D.Blake, J.F.Gaudino, J.J.Garrey, R.Metcalf, A.T.Burkard, M.Martinson, M.Rasor, K.Chen, H.Dean, B.Gould, S.E.Pacheco, P.Shahidi-Latham, S.Yin, J.West, K.Wang, W.Moffat, J.G.Schwarz, J.B.

(2015) J Med Chem 58: 1976-1991

  • DOI: 10.1021/jm501921k
  • Structures With Same Primary Citation

  • PubMed Abstract: 
  • Using structure-based design, a novel series of pyridone ERK1/2 inhibitors was developed. Optimization led to the identification of (S)-14k, a potent, selective, and orally bioavailable agent that inhibited tumor growth in mouse xenograft models. On ...

    Using structure-based design, a novel series of pyridone ERK1/2 inhibitors was developed. Optimization led to the identification of (S)-14k, a potent, selective, and orally bioavailable agent that inhibited tumor growth in mouse xenograft models. On the basis of its in vivo efficacy and preliminary safety profiles, (S)-14k was selected for further preclinical evaluation.


    Organizational Affiliation

    Array BioPharma Inc, 3200 Walnut Street, Boulder, Colorado 80301, United States.



Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Mitogen-activated protein kinase 1
A, B
349Homo sapiensMutation(s): 0 
Gene Names: MAPK1ERK2PRKM1PRKM2
EC: 2.7.11.24
Find proteins for P28482 (Homo sapiens)
Go to UniProtKB:  P28482
NIH Common Fund Data Resources
PHAROS  P28482
Protein Feature View
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
41B
Query on 41B

Download CCD File 
A, B
1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-(tetrahydro-2H-pyran-4-ylamino)pyrimidin-4-yl]pyridin-2(1H)-one
C22 H22 Cl F N4 O3
PGGLRAWFUJMQBN-HXUWFJFHSA-N
 Ligand Interaction
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
NEP
Query on NEP
A,BL-PEPTIDE LINKINGC6 H10 N3 O5 PHIS
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
41BKi:  0.4000000059604645   nM  BindingDB
41BKi:  0.6000000238418579   nM  BindingDB
41BIC50:  3.9000000953674316   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.58 Å
  • R-Value Free: 0.244 
  • R-Value Work: 0.208 
  • R-Value Observed: 0.210 
  • Space Group: P 41 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 83.191α = 90
b = 83.191β = 90
c = 274.493γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

  • Deposited Date: 2015-01-08 
  • Released Date: 2015-09-16 
  • Deposition Author(s): Yin, J., Wang, W.

Revision History 

  • Version 1.0: 2015-09-16
    Type: Initial release